Milestone Pharmaceuticals Inc.
NASDAQMIST short interest plummets 26% in one week to 9.21% of float, though utilization surges to 78%—highest level since early May.
Snapshot as of 28 Jun 2026
Milestone Pharmaceuticals enters the post-earnings session with a split signal: shorts retreated sharply ahead of the Q1 print, yet the numbers themselves disappointed. Short interest collapsed 26% in the week to May…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MIST — free to start on ORTEX.
Sign up for free →Open MIST on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live MIST data →